Prominence of withdrawal symptoms in polydrug-exposed infants

Journal of Perinatal and Neonatal Nursing

Volumn 14, Issue 4, 2001, Pages 46-60

  D'Apolito, Karen ^a   Hepworth, Joseph T ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Chemical dependency; Drug abuse; Infant; Infant withdrawal; Polydrug abuse; Withdrawal

Indexed keywords

NARCOTIC AGENT;

ALCOHOLIC BEVERAGE; ARTICLE; CANNABIS SMOKING; FEMALE; HUMAN; NEWBORN; PREGNANCY; SMOKING; WITHDRAWAL SYNDROME;

ALCOHOLIC BEVERAGES; FEMALE; HUMANS; INFANT, NEWBORN; MARIJUANA SMOKING; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; SMOKING;

EID: 0035296140     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005237-200103000-00005     Document Type: Article

References (35)

1. Mathias R. NIDA survey provides first national data on drug use during pregnancy. NIDA Notes. 1995;10:6-7, 19.
2. National Institute on Drug Abuse. National Household Survey on Drug Abuse: Population Estimates. Rockville, Maryland: NIDA; 1985.
3. NIDA Infofax. Report from National Household Survey on Drug Abuse. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 2000.
4. Chasnoff IJ. Newborn infants with drug withdrawal symptoms. Pediatr Rev. 1988;9:273-277.
5. Finnegan L, Kaltenbach K. Neonatal abstinence syndrome. In: Hoekelman PA, Friedman NB, Nelson NB, Seidel HM, eds. Primary Pediatric Care. St. Louis, MO: C.V. Mosby; 1992.
6. Als H. Toward a synactive theory of development: Promise for the assessment and support of infant individuality. Infant Mental Health J. 1982;3:229-243.
7. Torrence C, Horns K. Appraisal and caregiving for the drug addicted infant. Neonat Network. 1989;8:49-59.
8. Alderman E. Opiates. Pediatr Rev. 1997;18: 122-126.
9. American Academy of Pediatrics: Committee on Drug Withdrawal. Neonatal drug withdrawal. Pediatrics. 1998;101:1079-1088.
10. Coghlan D, Mimer M, Clark T, et al. Neonatal abstinence syndrome. Ireland Med J. 1999;92:232-233, 236.
11. Suresh S, Anand KJ. Opioid tolerance in neonates: Mechanisms, diagnosis, assessment, and management. Sem Perinat. 1998;22:425-433.
12. Fabris C, Prandi G, Perathoner C, Soldi A. Neonatal drug addiction. Panminerva Medica. 1998;40:239-243.
13. Scott CS, Decker JL, Edwards ML, Freid EB. Withdrawal after narcotic therapy: A study of neonatal and pediatric clinicians. Pharmacotherapy. 1998;18:1308-1312.
14. Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Dis: Int J. 1975;2:187-199.
15. Wachsman L, Schuetz S, Chan LS, Wingert WA. What happens to babies exposed to phencyclidine (PCP) in utero? Am J Drug Alcohol Abuse. 1989;15:31-39.
16. Alroomi LG, Davidson J, Evan TJ, Galea P, Howat. Maternal narcotic abuse and the newborn. Arch Dis Child. 1988;63:81-83.
17. Gregg JE, Davidson MF, Brazelton TB. Stages of behavioral organization in the high-risk neonate: Theoretical and clinical considerations. Sem Perinatol. 1988;296: 754.
18. Finnegan LP, McNew BA. Care of the addicted infant. Am J Nurs. 1974;74:685-693.
19. Kron RE, Kaplan SL, Finnegan LP, Litt M, Phoenix MD. The assessment of behavioral changes in infants undergoing narcotic withdrawal: Comparative data from clinical and objectives methods. Addictive Dis: Int J. 1975;2:257-275.
20. Rosette H, Ouellette E, Weiner L, Owens E. Therapy of heavy drinking during pregnancy. Obstet Gynecol. 1988;51:41-46.
21. Desmond MM, Schwanecke RP, Wilson CS, Yasunaga S, Burgdorff I. Maternal barbiturate utilization and neonatal withdrawal symptomatology. J Pediatr. 1972; 80:190-197.
22. Powell JJ. The tragedy of fetal alcohol syndrome. RN. 1981;33:94-96.
23. Zelson C. Acute management of neonatal addiction. Addictive Dis: Int J. 1975;2:159-168.
24. Scher MS, Richardson GA, Coble PA, Day NL, Stoffer DS. The effects of prenatal alcohol and marijuana exposure: Disturbances in neonatal sleep, cycling and arousal. Pediatr Res. 1988;24:101-105.
25. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates. J Pediatr. 1987;111:571-578.
26. Suresh S, Anand KJS. Opiate tolerance in neonates: Mechanisms, diagnosis, assessment & management. Sem Perinatol. 1998;22:425-433.
27. Finnegan L, Connaughton J, Kron R, Emich J. Neonatal abstinence syndrome: Assessment and management. Addictive Dis: Int J. 1975;2:141-158.
28. Misra A, Pontani R, Vadlamani N. Stereospecific potentiation of opiate analgesia by cocaine: Predominant role of noradrenaline. Pain. 1987;28:129-138.
29. Gomby D, Shiono PH. Estimating the number of substance-exposed infants. Future Child. 1991;1:17-25.
30. Fried PA, Makin JE. Neonatal behavior correlates of prenatal exposure in a low risk population. Neurotoxicol Teratol. 1987;9:1-7.
31. Finnegan LP, Ehrlich S. Maternal drug abuse during pregnancy: Evaluation and pharmacotherapy for neonatal abstinence. In: Modern Methods in Pharmacology. New York: Wiley Liss, Inc; 1990.
32. D'Apolito K. Comparison of a rocking-bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. J Maternal Child Nurs. 1999;24:138-144.
33. D'Apolito F. A scoring system for assessing neonatal abstinence syndrome: Videotape inter-observer reliability program. University of Washington School of Nursing; 1994.
34. Als H, Vandenberg K. An approach to implementing developmental intervention: What does developmental care involve. Paper presented at the Developmental Interventions in Neonatal Care Conference, New Orleans, November 7, 2000.
35. Harrison L. Research utilization: Handling preterm infants in the NICU. Neonat Network. 1997;16:65-69.